scholarly journals Early attention impairment in a patient with COVID‐19

Author(s):  
Júlio César Tolentino ◽  
Ana Lúcia Taboada Gjorup ◽  
Guilherme Janeiro Schmidt ◽  
Sergio Luis Schmidt
Keyword(s):  
2019 ◽  
Vol 50 (13) ◽  
pp. 2203-2212 ◽  
Author(s):  
Arielle S. Keller ◽  
Tali M. Ball ◽  
Leanne M. Williams

AbstractBackgroundAttention impairment is an under-investigated feature and diagnostic criterion of Major Depressive Disorder (MDD) that is associated with poorer outcomes. Despite increasing knowledge regarding mechanisms of attention in healthy adults, we lack a detailed characterization of attention impairments and their neural signatures in MDD.MethodsHere, we focus on selective attention and advance a deep multi-modal characterization of these impairments in MDD, using data acquired from n = 1008 patients and n = 336 age- and sex-matched healthy controls. Selective attention impairments were operationalized and anchored in a behavioral performance measure, assessed within a battery of cognitive tests. We sought to establish the accompanying neural signature using independent measures of functional magnetic resonance imaging (15% of the sample) and electroencephalographic recordings of oscillatory neural activity.ResultsGreater impairment on the behavioral measure of selective attention was associated with intrinsic hypo-connectivity of the fronto-parietal attention network. Not only was this relationship specific to the fronto-parietal network unlike other large-scale networks; this hypo-connectivity was also specific to selective attention performance unlike other measures of cognition. Selective attention impairment was also associated with lower posterior alpha (8–13 Hz) power at rest and was related to more severe negative bias (frequent misidentifications of neutral faces as sad and lingering attention on sad faces), relevant to clinical features of negative attributions and brooding. Selective attention impairments were independent of overall depression severity and of worrying or sleep problems.ConclusionsThese results provide a foundation for the clinical translational development of objective markers and targeted therapeutics for attention impairment in MDD.


2013 ◽  
Vol 27 (2) ◽  
pp. 337-341 ◽  
Author(s):  
Caterina Cerminara ◽  
Elisa D'Agati ◽  
Livia Casarelli ◽  
Ivo Kaunzinger ◽  
Klaus W. Lange ◽  
...  

Assessment ◽  
1996 ◽  
Vol 3 (2) ◽  
pp. 157-163 ◽  
Author(s):  
Wiley Mittenberg ◽  
Geoffrey Tremont ◽  
Katrina R. Rayls

The Wechsler Memory Scale—Revised (WMS-R), Wechsler Adult Intelligence Scale-Revised (WAIS-R), and Minnesota Multiphasic Personality Invcntory-2 (MMPI-2) were completed by 88 outpatients at a neuropsychology clinic who had diagnoses of central nervous system dysfunction. Extent of IQ, memory, or attention impairment were associated with elevations on MMPI-2 validity scales. Magnitude of estimated IQ loss separated valid from invalid profile groups more clearly than did obtained Full Scale IQ. Nonresponsivity to item content is probable when the patient scores below 70 on the WMS-R Memory or Attention/Concentration indexes, or earns a WAIS-R IQ that falls 20 points or more below expected premorbid level. These effects appear to be relatively independent of the patient's measured reading or intellectual levels. The MMPI-2 appears to provide valid information about the emotional status of patients with moderate and mild neurocognitive impairment.


2012 ◽  
Vol 27 (3) ◽  
pp. 199-209 ◽  
Author(s):  
Vicki Anderson ◽  
Senem Eren ◽  
Rian Dob ◽  
Robyne Le Brocque ◽  
Greg Iselin ◽  
...  

2007 ◽  
Vol 42 (7) ◽  
pp. 481-486 ◽  
Author(s):  
Arve Asbjørnsen ◽  
Anders Holmefjord ◽  
Sigvor Reisaeter ◽  
Per Møller ◽  
Olav Klausen ◽  
...  

2012 ◽  
Vol 136 ◽  
pp. S148-S149 ◽  
Author(s):  
Gricel P. Orellana ◽  
Marcela Peña ◽  
Andrea Slachevsky

2018 ◽  
Vol 0 (2.96) ◽  
pp. 19-25
Author(s):  
T.I. Nasonova ◽  
T.V. Kolosova ◽  
T.M. Slobodyn ◽  
O.V. Klymenko ◽  
I.V. Kurochkin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document